← Contracts
PT
Aquisição de Cisplatina 1 mg/ml sol inj fr 100 ml IV, Cisplatina 1 mg/ml sol inj fr 50 ml IV, Icatibant 30 mg/3 ml sol inj ser 3 ml SC, Oxaliplatina 5 mg/ml sol inj fr 40 ml IV e Pertuzumab 60 mg/ml + Trastuzumab 60 mg/ml sol inj fr 10 ml SC
ID 11666422
· Portal BASE
Price
Base Price
€73,063
.00
Effective Price
€27,780
.00
-62.0%
Contract Details
- Contract Type
- Aquisição de bens móveis
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
- CPV Code
- 33600000
- Location
- Portugal, Lisboa, Lisboa
- Bidder Count
- —
Winner
FRESENIUS KABI PHARMA PORTUGAL LDA
NIF 504293753
Dates
- Publication
- 28 Aug 2025
- Celebration
- 21 Aug 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api
· synced 2026-04-17
Risk Flags
Score 45 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
- Base price
- 73063.0
- Threshold
- 75000.0
- Rule
- A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
- Base price
- 73063.0
- Total effective price
- 27780.0
- Ratio
- 0.3802
- Direction
- reduction
- Rule
- A9 price reduction: ratio 0.3802 outside [0.5, 1.5]
Detected 2026-03-06